Acute phase proteins as potent early biomarkers for the detection of <i>Escherichia coli</i> infection in white New Zealand rabbits. [PDF]
Ali AA +3 more
europepmc +1 more source
Isolierung von β1A/C-Globulin aus menschlichem Serum mittels Hydroxylapatit- und DEAE-Cellulose-Säulenchromatographie [PDF]
D. Roelcke
openalex +1 more source
THE EFFECT OF LECITHINASE ON HUMAN SERUM GLOBULINS [PDF]
openaire +2 more sources
The antigenicity of serum proteins and their role in xenograft rejection [PDF]
Celli, S +9 more
core
The 100‐day non‐relapse mortality after single‐unit cord blood transplantation significantly declined from 19.6% (2003–2007) to 9.5% (2018–2022), while the 3‐year overall survival improved from 38.8% to 54.4%. Haematopoietic recovery rates improved steadily, with neutrophil engraftment reaching 89.6% and platelet engraftment 78.0% in the most recent ...
Takaaki Konuma +19 more
wiley +1 more source
Percent Pulmonary Damage on Hospital Admission is Predictive of COVID-19 Aggravation, but Serum Protein Electrophoresis is Not. [PDF]
Mascio SD +4 more
europepmc +1 more source
Summary The efficacy of ciclosporin (CsA) to treat transfusion‐independent non‐severe aplastic anaemia (TI‐NSAA) has not yet been systematically evaluated. We conducted a prospective trial in patients with TI‐NSAA treated with CsA monotherapy. CsA (3.5 mg/kg/day) was administered to patients with TI‐NSAA aged ≥16.
Ken Ishiyama +14 more
wiley +1 more source
Fecal Microbiota Transplantation in Patients with Alcohol-Associated Cirrhosis: A Clinical Trial. [PDF]
Ichim C +4 more
europepmc +1 more source
Specific agglutination of tanned red cells coated with a globulin fraction of an antithyroid serum by saline extracts of thyroid glands [PDF]
Iona M. MacLeod
openalex +1 more source
Treatment options for immune‐related adverse events associated with immune checkpoint inhibitors
Abstract The immunotherapy revolution with the use of immune checkpoint inhibitors (ICIs) started with the clinical use of the first ICI, ipilimumab, in 2011. Since then, the field of ICI therapy has rapidly expanded — with the FDA approval of 10 different ICI drugs so far and their incorporation into the therapeutic regimens of a range of malignancies.
Yu Hua Chen +3 more
wiley +1 more source

